I think it’s important to remind the member opposite and everyone that Ontario continues to monitor Health Canada’s regulatory approach to drugs for rare diseases and how it can impact our communities. Some of the changes outlined mean that we have seen Health Canada and Canadian Blood Services make some partnerships with others to ensure that we have critical plasma supply in the province of Ontario. There is no doubt the plasma supply need increases. It is a critical part of what we need to do every time there are operations in the province of Ontario.

Canadian Blood Services has made some partnerships, and we will watch to ensure that they follow all Ontario regulatory pieces.

We will monitor what Canadian Blood Services is doing. But I do not want to lose sight of the fact that donations of blood, donations of plasma, donations of organs are a critical part of our health care system, and that voluntary piece is some of the work that Canadian Blood Services does.